Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;42(7):821-828.
doi: 10.1097/ICO.0000000000003142. Epub 2022 Oct 17.

Autoantibodies Against Trisulfated Heparin Disaccharide and Fibroblast Growth Factor Receptor-3 May Play a Role in the Pathogenesis of Neuropathic Corneal Pain

Affiliations

Autoantibodies Against Trisulfated Heparin Disaccharide and Fibroblast Growth Factor Receptor-3 May Play a Role in the Pathogenesis of Neuropathic Corneal Pain

Betul N Bayraktutar et al. Cornea. .

Abstract

Purpose: The aim of this study was to describe cases of patients with presumable dysimmune small-fiber neuropathy (SFN)-related neuropathic corneal pain (NCP), presenting with autoantibodies against trisulfated heparin disaccharide (TS-HDS) or fibroblast growth factor receptor-3 (FGFR-3).

Methods: This study was a case series of 3 patients with NCP with positive anti-TS-HDS and/or anti-FGFR-3 autoantibodies and systemic SFN as confirmed by positive skin biopsy results.

Results: All 3 patients were women with a mean age of 34.3± 6.1 years. They suffered from moderate to severe persistent chronic ocular discomfort (10/10, 10/10, and 9/10 on a visual analogue scale, respectively). Although 1 patient suffered from ocular pain and photophobia alone, the other 2 patients experienced additional non-ocular pain. One of the patients had pain on her face and head, and 1 patient reported neck and lower back pain. Two patients had high anti-TS-HDS IgM titers, whereas 1 patient had both high anti-TS-HDS IgM and anti-FGFR-3 IgG titers. Skin biopsy confirmed the presence of SFN in all patients by demonstrating decreased intraepidermal nerve fiber density.

Conclusions: The presence of anti-TS-HDS and anti-FGFR-3 autoantibodies in patients with NCP with positive skin biopsy findings for SFN highlights the potential role of dysimmune SFN in the pathogenesis of this disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest statement: The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Comparison of central corneal nerve densities and nerve fiber numbers between cases and healthy control group. A) The mean total nerve density was 10,279.0±1,542.9 μm/mm2 in cases and 24,762.3±4,661.3 μm/mm2 in healthy controls. B) The mean nerve fiber number was 5.8±1.0 fiber/frame in cases and 26.6±2.1 fiber/frame in healthy controls.
Figure 2.
Figure 2.
In Vivo Laser Confocal Microscopy Images (HRT3/RCM, Heidelberg Engineering GmbH, Heidelberg, Germany). IVCM images demonstrated corneal nerves in a healthy eye (A) and extremely damaged corneal nerves and presence of microneuromas (white arrows) in, Case 2 (B), and Case 3 (C).
Figure 3.
Figure 3.
In Vivo Laser Confocal Microscopy Images (HRT3/RCM, Heidelberg Engineering GmbH, Heidelberg, Germany). IVCM images demonstrated dendritiform cells (white arrows) in patient corneas; Case 1 (A), slightly increased DC density in Case 2 (B) and Case 3 (C).

Similar articles

Cited by

References

    1. Farhad K Current Diagnosis and Treatment of Painful Small Fiber Neuropathy. Curr Neurol Neurosci Rep. 2019;19(12):103. - PubMed
    1. Sopacua M, Hoeijmakers JGJ, Merkies ISJ, Lauria G, Waxman SG, Faber CG. Small-fiber neuropathy: Expanding the clinical pain universe. J Peripher Nerv Syst. 2019;24(1):19–33. - PubMed
    1. Oaklander AL, Nolano M. Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review. JAMA Neurol. 2019. - PMC - PubMed
    1. Basantsova NY, Starshinova AA, Dori A, Zinchenko YS, Yablonskiy PK, Shoenfeld Y. Small-fiber neuropathy definition, diagnosis, and treatment. Neurol Sci. 2019;40(7):1343–50. - PubMed
    1. Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio V, Vitale DF, Loavenbruck A, et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol. 2018;25(6):848–53. - PubMed